Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ICLR – ICON Public Limited Company

Float Short %

2.71

Margin Of Safety %

14

Put/Call OI Ratio

0.57

EPS Next Q Diff

0.36

EPS Last/This Y

3.69

EPS This/Next Y

0.9

Price

175.95

Target Price

216.27

Analyst Recom

1.79

Performance Q

38.46

Relative Volume

0.88

Beta

1.2

Ticker: ICLR




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25ICLR187.080.411.007030
2025-07-28ICLR189.760.442.557156
2025-07-29ICLR185.170.430.087184
2025-07-30ICLR181.40.430.347284
2025-07-31ICLR169.130.431.717423
2025-08-01ICLR166.260.450.987533
2025-08-04ICLR164.860.443.297594
2025-08-05ICLR165.980.450.257635
2025-08-06ICLR155.380.443.367612
2025-08-07ICLR158.030.462.127713
2025-08-08ICLR158.540.470.537830
2025-08-11ICLR159.030.470.167846
2025-08-12ICLR169.110.470.037857
2025-08-13ICLR176.340.450.798062
2025-08-14ICLR175.280.4678.638049
2025-08-15ICLR175.860.571.428642
2025-08-18ICLR178.610.570.056622
2025-08-19ICLR179.510.570.046644
2025-08-20ICLR180.230.570.676646
2025-08-21ICLR175.780.573.006649
2025-08-22ICLR176.090.570.056665
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25ICLR187.01-15.1215.913.25
2025-07-28ICLR189.65-0.4116.113.30
2025-07-29ICLR185.21-0.5239.013.29
2025-07-30ICLR181.50-0.2243.113.30
2025-07-31ICLR169.19-0.5193.713.30
2025-08-01ICLR166.44-0.5246.813.30
2025-08-04ICLR164.80-0.5253.313.30
2025-08-05ICLR165.98-0.5270.413.30
2025-08-06ICLR155.49-0.5199.513.30
2025-08-07ICLR157.85-0.5278.713.30
2025-08-08ICLR158.44-0.5266.913.30
2025-08-11ICLR159.73-0.5271.313.30
2025-08-12ICLR168.98-0.5320.713.30
2025-08-13ICLR176.29-0.5306.213.30
2025-08-14ICLR175.28-0.5257.313.30
2025-08-15ICLR175.81-0.6265.813.29
2025-08-18ICLR178.70-0.6279.713.29
2025-08-19ICLR179.64-0.6269.313.29
2025-08-20ICLR180.22-0.6266.413.29
2025-08-21ICLR175.75-0.6237.713.29
2025-08-22ICLR175.95-0.6264.613.29
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25ICLR0.00-7.882.77
2025-07-28ICLR0.00-7.872.77
2025-07-29ICLR0.00-7.872.77
2025-07-30ICLR0.00-7.872.88
2025-07-31ICLR0.00-7.872.88
2025-08-01ICLR0.00-7.872.88
2025-08-04ICLR0.00-7.112.88
2025-08-05ICLR0.00-7.112.88
2025-08-06ICLR0.00-7.112.88
2025-08-07ICLR0.00-7.112.88
2025-08-08ICLR0.00-7.112.88
2025-08-11ICLR0.00-6.602.88
2025-08-12ICLR0.00-6.602.71
2025-08-13ICLR0.00-6.602.71
2025-08-14ICLR0.00-6.602.71
2025-08-15ICLR0.00-6.602.71
2025-08-18ICLR0.00-9.622.71
2025-08-19ICLR0.00-9.622.71
2025-08-20ICLR0.00-9.622.71
2025-08-21ICLR0.00-9.622.71
2025-08-22ICLR0.00-9.622.71
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

3.16

Avg. EPS Est. Current Quarter

3.33

Avg. EPS Est. Next Quarter

3.52

Insider Transactions

Institutional Transactions

-9.62

Beta

1.2

Average Sales Estimate Current Quarter

1996

Average Sales Estimate Next Quarter

2008

Fair Value

200.42

Quality Score

76

Growth Score

82

Sentiment Score

91

Actual DrawDown %

49.4

Max Drawdown 5-Year %

-63.4

Target Price

216.27

P/E

18.07

Forward P/E

12.39

PEG

4.97

P/S

1.69

P/B

1.43

P/Free Cash Flow

13.82

EPS

9.73

Average EPS Est. Cur. Y​

13.29

EPS Next Y. (Est.)

14.19

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

9.82

Relative Volume

0.88

Return on Equity vs Sector %

-16.4

Return on Equity vs Industry %

-2.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

264.6
ICON plc
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 39900
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
stock quote shares ICLR – ICON Public Limited Company Stock Price stock today
news today ICLR – ICON Public Limited Company stock forecast ,stock prediction 2023 2024 2025
marketwatch ICLR – ICON Public Limited Company yahoo finance google finance
stock history ICLR – ICON Public Limited Company invest stock market
stock prices ICLR premarket after hours
ticker ICLR fair value insiders trading